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Abstract 
Objective: Previous longitudinal studies suggest that depression and anxiety are associated with 
risk for cardiovascular disease. The aim of the present study was to test whether an association 
between depression/anxiety symptoms and retinal vessel caliber, an indicator of subclinical 
cardiovascular risk, is apparent as early as adolescence and young adulthood. 
Methods: Participants were 865 adolescents and young adults who participated in the Brisbane 
Longitudinal Twin Study and the Twin Eye Study in Tasmania. Participants completed 
assessments of depression/anxiety and somatic symptoms when they were M=16.5 years, and 
they underwent retinal imaging M=2.5 years later (range=2 years before to 7 years after the 
depression/anxiety assessment). Retinal vessel caliber was assessed using computer software. 
Results: Depression/anxiety symptoms were associated with wider retinal arteriolar caliber in 
this sample of adolescents and young adults (β=0.09, p=.016), even after adjusting for other 
cardiovascular risks (β=0.08, p=.025). Multiple regression analyses revealed that affective 
symptoms of depression/anxiety were associated with retinal vessel caliber independently of 
somatic symptoms. 
Conclusions: Depression/anxiety symptoms are associated with measurable signs in the retinal 
microvasculature in early life, suggesting that pathological microvascular mechanisms linking 
depression/anxiety and cardiovascular disease may be operative from a young age.   
 
KEY WORDS: depression, anxiety, retinal vessel caliber, cardiovascular, adolescence, young 
adults 
ABBREVIATIONS: SPHERE = Somatic and Psychological Health Report; CRAE=central 
retinal arteriolar equivalent; CRVE=central retinal venular equivalent; BMI=body mass index; 
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MABP=mean arterial blood pressure; MZ=monozygotic; DZ=dizygotic; BLTS=Brisbane 
Longitudinal Twin Study; DSM=Diagnostic and Statistical Manual of Mental Disorders; 
IRT=item response theory.  
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Associations between Depression/Anxiety Symptoms and Retinal Vessel Caliber  
in Adolescents and Young Adults  
Longitudinal studies have shown that individuals with symptoms of depression and 
anxiety are at increased risk for developing cardiovascular disease, and this association persists 
after accounting for traditional cardiovascular risk factors (1-7). Depression has even been found 
to confer risk for coronary events up to 10 years later (2). This finding suggests that the 
pathophysiological mechanisms linking depression with cardiovascular disease may be operative 
years before the clinical manifestation of cardiovascular disease, and it highlights the need for 
studies of depression and anxiety and subclinical markers of cardiovascular disease in early life.   
One increasingly recognized marker of early subclinical cardiovascular disease is the 
caliber of the retinal microvessels (8). Advances in digital retinal photography and retinal image 
computer analysis now allow for the accurate quantitative assessment of the condition of small 
retinal blood vessels in large population-based samples (8, 9). Retinal microvessels can be used 
to gauge the health of the microcirculation, because the retina shares anatomical and 
physiological features with other end organs (e.g., heart, brain, kidneys) (10, 11). Research has 
shown, for example, that retinal vessel caliber predicts risk of coronary heart disease, stroke, 
cerebral small vessel disease, cognitive impairment, and dementia (8, 12-15).  
Fewer than a dozen studies have examined associations of depression and anxiety with 
retinal vessel caliber (16-25) (Table 1). These studies have generally shown that adults with 
depression and/or anxiety exhibit deviations in retinal vessel caliber, either wider or narrower 
arterioles or venules, suggesting that microvascular abnormality may underlie the association 
between depression and anxiety symptoms and cardiovascular disease. Yet these studies have 
primarily focused on older adults. Given mounting evidence that depression, anxiety, and 
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cardiovascular disease have their roots in childhood (26-30), we tested whether an association 
between depression/anxiety symptoms and retinal vessel caliber is apparent as early as 
adolescence and young adulthood. In addition, because affective depression and anxiety 
symptoms often co-occur with somatic symptoms (i.e., fatigue and pain) (31) that may 
themselves be related to retinal vessel caliber, we differentiated between affective symptoms of 
depression/anxiety and somatic symptoms.  
Methods 
Participants 
Participants were members of the population-based Brisbane Longitudinal Twin Study 
(BLTS), an ongoing longitudinal study of adolescent and young-adult monozygotic (MZ) and 
dizygotic (DZ) twin pairs and their siblings (32, 33). As described in detail elsewhere (32, 33), 
twins were initially recruited to the study from primary and secondary schools in South East 
Queensland in 1992, with new twins added at various intervals. All schools in South East 
Queensland were approached, and all regions in South East Queensland were represented. 
Comparisons of this sample with other population-based samples suggest that this sample is 
representative with respect to a variety of traits, including, for example, personality (34) and 
retinal vessel caliber (35, 36). 
Mental health data were collected on up to four occasions between 2000 and 2013 as part 
of the study of skin mole development (37) as well as the study of cognition (32), and the study 
of health and well-being (32, 33). A subset of participants also completed an extensive eye 
examination in 2004-2008 as part of the Twins Eye Study of Tasmania (38, 39). Here were 
report on 865 participants for whom both mental health data (mean age across 
assessments=16.52, SD=2.96) and eye exam (mean age=19.07, SD=3.53) data were available. 
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Though the eye exam was conducted M=2.55 (SD=1.57) years after the mental health 
assessment, the eye exam took place anywhere from 2 years before to as many as 7 years after 
the mental health assessment. The study was approved by the ethics committees of the Royal 
Victorian Eye and Ear Hospital, the Royal Hobart Hospital, and the QIMR Berghofer Medical 
Research Institute, as well as the Australian Twin Registry, and adhered to the tenets of the 
Declaration of Helsinki. Written informed consent was obtained from all of the participants or 
their legal guardians, with the participants’ assent before examination. 
Measures 
 Depression/anxiety, somatization, and fatigue. The Somatic and Psychological Health 
Report (SPHERE) questionnaire is a 34-item self-report questionnaire that assesses common 
symptoms of depression, anxiety, and somatic distress (40-42). In addition to yielding a total 
score indexing overall mental health and well-being, the SPHERE yields subscale scores 
indexing primarily affective symptoms of depression/anxiety (14 items; e.g. “feeling irritable or 
cranky”, “feeling unhappy and depressed”, “everything getting on top of you”), somatization (10 
items; e.g. “joint pain”, “weak muscles”), and fatigue (9 items; e.g. “poor sleep”, “prolonged 
tiredness after activity”, “poor concentration”). Participants indicated if they had been troubled 
by symptoms over the past few weeks.  
The SPHERE has been shown to have adequate reliability and validity (33, 40, 41). 
Internal consistency reliability for the SPHERE and the depression/anxiety, somatization, and 
fatigue subscales was 0.89, 0.84, 0.70, and 0.75, respectively (40). A prior study showed that the 
SPHERE accurately identified 93% of individuals with current DSM depression, anxiety, or 
somatoform disorders (41).  Moreover, the depression/anxiety subscale shows substantial 
heritability (40%) and correlates strongly with the personality trait of neuroticism (r=0.64) (40).  
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Item response theory (IRT) analysis of the SPHERE items was implemented in 
WINBUGS2 (43) to estimate latent liability scores reflecting (a) liability to depression/anxiety 
(based on the 14 items of the SPHERE depression/anxiety subscale; 1 item overlaps with 
somatization, and 3 items overlap with fatigue), (b) liability to somatization (based on the 10 
items of the SPHERE somatization subscale, 1 item overlaps with fatigue), (c) liability to fatigue 
(based on the 9 items of the SPHERE fatigue subscale), and (d) poor overall mental health and 
well-being (based on all 34 items of the SPHERE). High scores on the latent liability indexes 
reflect that participants endorsed many symptoms. Liability to depression/anxiety was 
significantly correlated with liability to somatization (r=0.54) and fatigue (r=.70), and liability to 
somatization and fatigue were also significantly correlated (r=0.63). Each subscale was 
significantly correlated with poor overall mental health (0.90, 0.69, and 0.87, respectively). 
Over half of the participants (n=479) had completed the SPHERE on more than one 
occasion as part of different studies (details published previously (40)). Data were collected only 
once for 386 participants (45%), twice for 152 (17%), three times for 233 (27%), and four times 
for 94 participants (11%). For participants who had completed the SPHERE on multiple 
occasions, we averaged the latent liability scores over occasions and took an ‘average age’ at 
assessment. Our rationale for aggregating the SPHERE data was that an aggregate estimate 
would be more reliable and accurate than an estimate from any single occasion.  
 Retinal vessel caliber. As described elsewhere (39, 44), all of the twins had 10° 
stereoscopic optic disc–centered photographs using a Nidek 3-Dx/F fundus camera (Nidek) after 
dilatation of the pupils with tropicamide 1% or cyclopentolate 1%. Photographs were digitalized, 
and retinal vessel caliber was measured with computer-assisted software (IVAN, University of 
Wisconsin, USA) according to a standardized protocol (45). Two trained graders, masked to 
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participant characteristics, performed the vessel measurements on the optic disc–centered image 
for both eyes for all of the participants. The largest 6 arterioles and venules coursing through a 
zone between half to 1 disc diameter from the optic disc margin were measured. Estimates were 
summarized as the central retinal arteriolar equivalent (CRAE) and central retinal venular 
equivalent (CRVE), representing the average caliber (diameter) of arterioles and venules of the 
eye, respectively, using a revised Knudtson-Parr-Hubbard formula (46). Reliability of the retinal 
vessel measurement has been published elsewhere (44). Intragrader variation was assessed in 67 
randomly selected retinal photographs. The intragrader intraclass correlation coefficient was 0.95 
for CRAE and 0.99 for CRVE. Intergrader reliability was assessed in 52 randomly selected 
retinal images, and the interclass correlation coefficient was 0.93 for CRAE and 0.98 for CRVE. 
The correlation between CRAE and CRVE was 0.51 (p<.001). 
Covariates. Smoking status and body mass index (BMI) were included as covariates, as 
they are associated with both retinal vessel caliber and mental health, in this sample and in others 
(8, 9, 47-50). Spherical equivalent and axial length were included as covariates in order to adjust 
for any potential effects of these parameters on retinal vessel caliber (45, 51). The Supplemental 
Table shows correlations of these covariates with vessel caliber and mental health. All analyses 
also controlled for age and sex. Covariates were assessed at the time of the eye exam. 
BMI was calculated as kilograms per meter squared. For participants who were missing 
either height or weight data or both (12%, n=102), we imputed the missing data using the 
multiple imputation procedure in SAS (SAS Institute, Inc., Cary, NC, USA). Axial length was 
measured using the IOL Master, and refractive errors were measured using a Humphrey-598 
automatic refractor (Carl Zeiss Meditec, Inc., Miami, Florida, USA). Spherical equivalent was 
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calculated using the standard formula of the algebraic sum of the dioptric powers of the sphere 
and half of the cylinder (38).   
Statistical Analysis 
To examine associations between mental health and retinal arteriolar caliber, we 
conducted separate linear regressions predicting arteriolar caliber from each mental health risk 
factor (i.e., we considered each predictor [depression/anxiety, somatization, fatigue, and overall 
mental health] individually). Associations between each predictor and retinal arteriolar caliber 
were initially adjusted for the effects of age and sex (Model 1) and then further adjusted for the 
effects of smoking status, BMI, sphericity, and axial length (Model 2). We then repeated these 
analyses with venular caliber as the outcome. We report standardized beta coefficients (β) from 
these analyses. To account for participants’ familial relatedness (the non-independence of 
observations), robust standard errors were computed using the SURVEYREG procedure in SAS 
(SAS Institute, Inc., Cary, NC, USA). This procedure downwardly adjusts the degrees of 
freedom based on the number of twin pairs in the analysis, taking into account that information 
obtained about one twin is related to information obtained about the co-twin. 
Results 
Descriptive statistics for measures of mental health and retinal vessel caliber are 
presented in Table 2.  
Table 3 shows associations between each mental health predictor and vessel caliber. 
Liability to depression/anxiety was associated with arteriolar (β=0.09, p=.016) but not venular 
caliber (β=0.00, p=.90) (Table 3, Model 1). Specifically, adolescents and young adults with a 
greater number of depression/anxiety symptoms showed wider arteriolar caliber (Figure 1). A 
similar pattern of associations was observed for somatization, fatigue, and overall mental health, 
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though effects for somatization and fatigue did not reach statistical significance. Notably, 
associations were unchanged after controlling for smoking status, BMI, sphericity, and axial 
length (Table 3, Model 2).  
As an additional check of these associations, we re-ran Model 2 analyses while also 
controlling for mean arterial blood pressure (MABP; calculated as 2/3 diastolic + 1/3 systolic 
blood pressure) in a subset of participants (n=291) who had their blood pressure taken as part of 
an earlier study (M age=14.27 years). MABP was associated with narrower arterioles (r=-0.18, 
p=.004), consistent with previous research, but was not associated with depression/anxiety (r=-
.01), somatization (r=-0.01), or fatigue (0.03). As such, associations between mental health 
measures and arteriolar caliber were unchanged from before to after controlling for MABP. For 
example, the association between depression/anxiety and arteriolar caliber was β=0.08 before 
and after controlling for MABP.   
Finally, in order to determine whether affective symptoms of depression/anxiety were 
associated with arteriolar caliber over and above somatic symptoms, we examined a model 
including depression/anxiety, somatization, and fatigue as simultaneous predictors of arteriolar 
caliber. (Smoking status, BMI, sphericity, axial length, age, and sex were included as covariates.) 
The association between depression/anxiety and arteriolar caliber was unchanged after 
additionally controlling for somatization and fatigue (β=0.08), though this association did not 
reach statistical significance (p=.099).  
Discussion 
We found that adolescents and young adults with symptoms of depression/anxiety had 
wider retinal arteriolar caliber. This is the first study, to our knowledge, to demonstrate an 
association between depression/anxiety and retinal vessel caliber in a young, otherwise healthy 
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population. Our finding is of interest because while depression and anxiety first develop in 
adolescence (52), cardiovascular diseases are typically not apparent until years later. Our finding, 
therefore, adds to a small but growing body of literature suggesting that the pathophysiological 
mechanisms linking depression and anxiety with cardiovascular disease may be operative from a 
young age (53-56), possibly at the level of the microvasculature.  
The specific pathophysiological mechanisms underlying wider arteriolar caliber are not 
entirely understood, but one hypothesized mechanism is endothelial dysfunction (impairment of 
nitric oxide-mediated vasodilation). Wider retinal arteriolar caliber is a sign of impaired 
autoregulation (57) and has been shown to be associated with reduced flicker-induced 
vasodilation (58). Notably, endothelial dysfunction is seen in individuals with depression and 
anxiety (5, 56, 59). For example, a meta-analysis reported a statistically significant overall 
correlation of 0.19 between depressed mood and reduced flow-mediated dilation in adults (59). 
Recent studies of children and adolescents have also shown an association between depression 
and anxiety and impaired endothelial function assessed using the EndoPAT device (54-56). 
Moreover, a study using arterial spin labeling technology demonstrated that adolescents 
diagnosed with depression showed altered cerebral perfusion (60), which could be consistent 
with impaired autoregulation. These findings further strengthen the possibility that abnormal 
vascular processes linking depression and anxiety to later cardiovascular disease may begin in 
childhood.  
Our finding of an association between depression/anxiety and wider arteriolar caliber in 
adolescents and young adults is generally consistent with three other studies of adults (18, 19, 
25), but findings in adults are inconsistent. A few studies of adults have shown an association 
between depression and narrower (rather than wider) arteriolar caliber and/or wider venular 
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caliber (Table 1). The reasons for the discrepancies across studies of adults are uncertain, but 
inconsistent findings may be attributable to methodological differences between studies, such as 
the age and overall physical health of the sample. Older adults have a higher prevalence of 
vascular risk factors that exert opposing influences on the microvasculature. For example, 
hypertension-induced arteriolar narrowing and sclerosis in older adults could obscure the effects 
of pathological vascular processes that might cause wider arteriolar caliber. The relative 
healthiness of the adolescents and young adults in the current study reduces the chances of such 
confounding by other cardiovascular risks. Another possible explanation for the mixed findings 
is that wider arteriolar caliber might reflect an early emerging microvascular abnormality, 
whereas wider venular caliber could reflect a more entrenched pathological process. Prospective 
longitudinal studies are needed to address this question.  
A limitation of the current study is that retinal vessel caliber was not assessed 
concurrently with depression/anxiety symptoms, which may have attenuated their association. 
We note, however, that the association between depression/anxiety and retinal arteriolar caliber 
was unchanged when we restricted the analyses to participants (n=345) for whom retinal imaging 
and depression/anxiety data were collected within 1 year of each other (β=0.09 in this subsample 
compared with the full sample estimate of β=0.09). A second limitation is that we only measured 
retinal vessel caliber at a single time point and, therefore, we cannot determine the temporal 
ordering of depression/anxiety symptoms and wider arteriolar caliber. The directional and causal 
nature of the association remains unclear. For example, wider arterioles may be a consequence of 
depression/anxiety. Conversely, depression/anxiety symptoms may result from wider arterioles 
or from shared mechanisms that contribute to both. A related limitation is that we did not use the 
twin design to determine whether common genetic or environmental factors contribute to the 
12 
 
association between depression/anxiety and retinal vessel caliber. Studies from this sample (as 
well as others) have shown that genetic factors play a significant role in retinal vessel caliber 
(39) and depression/anxiety (40). Moreover, a study of adult twins found a modest genetic 
correlation between depression and coronary artery disease (61). Thus, a natural question is 
whether the genetic factors underlying depression/anxiety and retinal vessel caliber overlap. The 
cross-twin, cross-trait correlations were fairly similar for MZ and DZ twins in this sample 
(MZ=0.09, -0.01; DZ=0.10, 0.12), suggesting a role for shared-environmental influences in the 
association between depression/anxiety and arteriolar caliber. However, these correlations were 
too small to reliably parse genetic and environmental influences. 
Third, we did not distinguish between depression and anxiety symptoms or assess 
clinically diagnosable depression and anxiety. Thus, it is unclear whether retinal vessel caliber 
may show differential associations with depression and anxiety symptoms or whether results will 
apply to those meeting diagnostic criteria for depression and anxiety disorders. Depression and 
anxiety disorders tap both affective and somatic symptoms, however, leaving some researchers 
to question whether somatic symptoms drive the association between depression and anxiety and 
cardiovascular disease (62, 63). A strength of our study is that we were able to distinguish 
between affective and somatic symptoms, and a multiple regression analysis suggested that 
affective symptoms of depression/anxiety may be useful indicators of cardiovascular risk. 
Nonetheless, ongoing data collection in our twins (33) will enable us to examine the association 
between retinal vessel caliber and clinical indices of depression and anxiety as well as provide a 
more powerful means of modeling direction of causation.  
This study has a number of implications. First, our finding that generally healthy 
adolescents and young adults with depression/anxiety symptoms have wider arteriolar caliber 
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suggests that depression/anxiety-associated cardiovascular risk may have its roots in childhood. 
Second, affective symptoms of depression/anxiety may identify youth at risk for cardiovascular 
disease. Therefore, routine screening for affective symptoms of depression and anxiety may be 
important for the cardiovascular health of young people as well as older adults (64). Third, 
retinal imaging is a simple, non-invasive, and cost-effective approach to assessing microvascular 
health in children, adolescents, and adults. Future research can use retinal imaging to address a 
variety of important questions. For example, longitudinal studies can address whether increases 
in depression and anxiety symptoms track with increases in retinal arteriolar caliber, and 
treatment studies can address whether improvement in depressive and anxiety symptoms is 
associated with changes in arteriolar caliber. In summary, we provide initial evidence that 
adolescents and young adults with depression/anxiety symptoms show microvascular 
abnormality, a finding that adds to a growing body of research suggesting that the link between 
depression/anxiety and cardiovascular disease dates back to childhood. 
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Table 1. Extant Studies of Depression and Anxiety and Retinal Vessel Caliber. Studies are generally organized by date, with studies using the same sample 
appearing together.  
      
Study Study Sample Analysis N 
Mean Age or 
Age Range 
(Years) Mental Health Index Finding 
      
      
1. Sun et al., 2007 (16) Cardiovascular Health Study 2,420 78.5 Short version of the CES-D. No association. 
      
2. Kim et al. 2011 (17) Cardiovascular Health Study  1,489 78.1 Short version of the CES-D. Depression 
associated with 
narrower arterioles.  
      
3. Nguyen et al., 2008 
(18) 
Clinic-based study of depressed 
(n=34) and non-depressed (n=27) 
individuals with Type 2 diabetes 
and healthy controls (n=38) 
99 56.5 DSM-IV criteria, Hamilton 
Depression Rating Scale, and 
Mattis Dementia Rating Scale. 
Some evidence that 
depression was 
associated with wider 
arterioles and 
venules. 
      
4. Nguyen et al. 2010 
(19) 
Clinic-based study of depressed 
(n=43) and non-depressed (n=49) 
individuals with Type 2 diabetes 
and healthy controls (n=54) 
146 57.8 DSM-IV criteria, Hamilton 
Depression Rating Scale, Mini 
Mental State Exam.  
Depression 
associated with wider 
arterioles. 
      
5. Cheung et al 2009 
(20) 
Atherosclerosis Risk in 
Communities Study 
10,339 56.5 Vital exhaustion assessed with 
the Maastricht questionnaire. 
Vital exhaustion 
associated with wider 
venules. 
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6. Ikram et al., 2010 
(21) 
Rotterdam Study 3,605 66.1 Various (CES-D or Hospital 
Anxiety and Depression Scale, 
structured interview, general 
practitioner and pharmacy 
records). 
No association. 
      
7. Jensen et al 2010 (22) Multi-Ethnic Study of 
Atherosclerosis  
>6,000 45-84 CES-D, Spielberger trait 
anxiety. 
Anxiety (but not 
depression) 
associated with 
narrower arterioles. 
      
8. Caspi et al 2013 (23) Dunedin Multidisciplinary Health 
and Development Study  
1,000 38 Structured diagnostic 
interviews used to create an 
internalizing latent factor 
indicated by depression, 
generalized anxiety disorder, 
fears/phobias. 
Internalizing 
associated with wider 
venules. 
      
9. Meier et al 2013 (24) Dunedin Multidisciplinary Health 
and Development Study.  
Subset of study 
members with 
persistent 
depression 
(n=188) versus 
healthy controls 
(n=412) 
38 Structured diagnostic 
interviews used to diagnose 
persistent depression. 
Persistent depression 
associated with wider 
venules and narrower 
arterioles.  
      
10. Li et al 2013 (25) Growing Up in Singapore 
Towards Healthy Outcomes Study 
& In Vitro Fertilization Study 
472-786 30.6 
 (26 weeks 
gestation) 
Edinburgh Postnatal 
Depression Scale, State-Trait 
Anxiety Inventory, Pittsburg 
Sleeping Quality Index. 
Depression and poor 
sleep quality (but not 
anxiety) associated 
with wider arterioles. 
Note. Analytic strategy and adjustment for other cardiovascular risks varied considerably across studies. 
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Table 2. Means and standard deviations for measures of mental health and retinal vessel caliber. 
       
 Full Sample Girls Boys 
 N=865 N=495 N=370 
       
Measure M SD M SD M SD 
       
SPHERE (range)       
       
Depression/Anxiety Subscale (0-14) 3.69 3.13 3.76 3.20 3.58 3.03 
       
Somatization Subscale (0-10) 1.62 1.59 1.63 1.66 1.61 1.50 
       
Fatigue Subscale (0-9) 2.95 1.98 2.83 1.95 3.10 2.01 
       
Overall Mental Health (0-34) 8.62 5.71 8.61 5.78 8.63 5.61 
       
Retinal Vessel Caliber (in µm)       
       
Arterioles 165.27 12.94 165.27 13.69 165.28 11.89 
       
Venules 249.54 17.96 248.81 18.51 250.52 17.17 
 
 
 
Note. Means for SPHERE (Somatic and Psychological Health Report) and retinal vessel caliber match published means for the larger 
studies from which these participants were drawn (38-40).
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Note: Results are from ordinary least squares regressions predicting arteriolar and venular caliber from each SPHERE liability score, 
with separate regressions conducted for each SPHERE liability score. a. Model 1 controls for age and sex. b. Model 2 controls for age, 
sex, smoking status, BMI (body mass index), sphericity, and axial length. SPHERE = Somatic and Psychological Health Report. 
β=standardized beta coefficients. SE = robust standard error. Statistically significant associations are bolded. 
 
 
Table 3. Associations between measures of mental health and retinal vessel caliber. 
              
 Arterioles  Venules 
 Model 1
a
 Model 2
b
 
 
Model 1
a
 Model 2
b
 
              
SPHERE Liability Score  β SE p β SE p  β SE p β SE p 
              
Depression/anxiety 0.09 .037 .016 0.08 .036 .025  0.00 .037 .90 -0.01 .035 .72 
              
Somatization 0.06 .035 .072 0.06 .035 .090  0.04 .035 .22 0.02 .034 .63 
              
Fatigue 0.06 .035 .099 0.05 .034 .11  0.00 .035 .94 -0.01 .033 .71 
              
Overall Mental Health  0.08 .036 .024 0.08 .036 .028  0.00 .038 .99 -0.02 .036 .67 
27 
 
 
 
 
 
 
Figure 1. Association between depression/anxiety and retinal arteriolar caliber. Adolescents and 
young adults with a greater number of depression and anxiety symptoms showed wider arteriolar 
caliber. Note. Depression symptoms were grouped such that the first and third categories roughly 
correspond to the bottom and top deciles of the sample. Raw means, unadjusted for covariates, 
are presented. The p-value indicates the results of a t-test comparing the group with no symptoms 
to the group with 9+ symptoms. Error bars = robust standard errors.  
 
 
 
p=.016 
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Supplemental Table. Correlations of covariates with vessel caliber and mental health. 
       
Covariate Arterioles Venules Depression/Anxiety Somatization Fatigue 
Overall Mental 
Health 
       
BMI -0.15 
(<.001) 
0.06 
(.094) 
0.04 
(.34) 
0.09 
(.029) 
0.06 
(.19) 
0.06 
(.16) 
       
Smoking Status 0.09 
(.003) 
0.10 
(.008) 
0.16 
(<.001) 
0.18 
(<.001) 
0.15 
(<.001) 
0.17 
(<.001) 
       
Sphericity 0.17 
(<.001) 
0.25 
(<.001) 
0.00 
(.91) 
0.02 
(.53) 
0.01 
(0.78) 
-0.01 
(.60) 
       
Axial Length -0.26 
(<.001) 
-0.35 
(<.001) 
-0.01 
(.83) 
-0.01 
(.71) 
0.01 
(.74) 
0.00 
(.91) 
       
 
Note. p-values are shown in parentheses. 
 
 
 
